Search results

Research represents significant step towards developing vaccine

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.

Researchers from the University of New South Wales have developed a new type of rechargeable battery that uses protons as charge carriers, offering a safer and more environmentally friendly alternative to conventional lithium-ion batteries.

Research to detect and measure air pollution, the composition the atmosphere and mixing in the atmosphere.

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.

ANSTO contributes to new international project to improve how the world assesses the economic viability of Small Modular Reactors

As a new or returning user, there are certain requirements that must be completed to ensure that your beamtime at the Australian Synchrotron runs smoothly.

Airbus Australia Pacific has provided students participating in ANSTO’s National Graduate Innovation Forum with a practical challenge relating to technology that is exposed to damaging radiation in space.

Using the Australian Synchrotron, an international team of researchers has characterised an important interaction that helps the SARS-CoV-2 virus invade human cells.

The first pilot project at the Australian Synchrotron takes place following a Memorandum of Understanding between nandin and Swinburne University of Technology and Design Factory Melbourne (DFM).

Australia’s new Mo-99 manufacturing facility reaches practical completion